Retrospective analysis reports no increased complications in T2DM patients with femoral neck fractures post-HA using GLP-1RA, suggesting safety for use.
Key Points
GLP-1RA use did not increase early postoperative medical complications in patients with type 2 diabetes mellitus.
The analysis involved 499 patients who underwent hip hemiarthroplasty for femoral neck fractures, with outcomes assessed up to 365 days.
Assessment used binary logistic regression to evaluate the association of GLP-1RA with various surgical outcomes and length of stay.
Findings highlight the safety of GLP-1RA in diabetic patients undergoing hip surgery, with no severe adverse outcomes noted.